Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1976 Feb;29(2):130–134. doi: 10.1136/jcp.29.2.130

Re-evaluation of heat precipitation method for plasma fibrinogen estimation: effect of abnormal proteins and plasma viscosity.

L Dintenfass, S Kammer
PMCID: PMC475989  PMID: 777032

Abstract

The heat precipitation method (Aberdeen method) was compared with the Ratnoff and Menzie method of fibrinogen assay in 320 donors, including normals and patients suffering from malignant melanoma, renal failure, hypertension, multiple myeloma, etc. Excellent correlation (r=0-8287, p less than 0-000 000 1) was found between these two methods. However, on some occasions individual low results were obtained by the Aberdeen method in the presence of cryoglobulins or excessively high plasma viscosity. The latter effect was tested also by additions of albumin, glucose, and dextrans.

Full text

PDF
130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COLLIER F. C., REICH A., KING J. W. Multiple myeloma; a report of four cases demonstrating Bence-Jones proteinemia found during routine complement-fixation tests. N Engl J Med. 1951 Dec 20;245(25):969–971. doi: 10.1056/NEJM195112202452504. [DOI] [PubMed] [Google Scholar]
  2. Dintenfass L., Forbes C. D. Effect of fibrinogen on aggregation of red cells and on apparent viscosity of artificial thrombi in haemophilia, myocardial infarction, thyroid disease, cancer and control systems: effect of ABO blood groups. Microvasc Res. 1975 Jan;9(1):107–118. doi: 10.1016/0026-2862(75)90055-2. [DOI] [PubMed] [Google Scholar]
  3. Dintenfass L. Significant effect of ABO blood groups on the aggregation of red cells in patients with diabetes mellitus. Role of fibrinogen and serum proteins. Microvasc Res. 1974 May;7(3):326–341. doi: 10.1016/0026-2862(74)90020-x. [DOI] [PubMed] [Google Scholar]
  4. Dormandy J. A., Gutteridge J. M., Hoare E., Dormandy T. L. Effect of clofibrate on blood viscosity in intermittent claudication. Br Med J. 1974 Nov 2;4(5939):259–262. doi: 10.1136/bmj.4.5939.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dormandy J. A., Hoare E., Colley J., Arrowsmith D. E., Dormandy T. L. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):576–581. doi: 10.1136/bmj.4.5892.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FOSTER J. B., DENATALE A., DOTTI L. B. Determination of plasma fibrinogen by means of centrifugation after heating. Am J Clin Pathol. 1959 Jan;31(1):42–45. doi: 10.1093/ajcp/31.1.42. [DOI] [PubMed] [Google Scholar]
  7. FRICK P. G. Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma. Am J Clin Pathol. 1955 Nov;25(11):1263–1273. doi: 10.1093/ajcp/25.11.1263. [DOI] [PubMed] [Google Scholar]
  8. Hart A., Cohen H., Thorp J. M. Lipoprotein and fibrinogen studies in diabetes. Postgrad Med J. 1971 Jun;47(Suppl):435–439. [PubMed] [Google Scholar]
  9. Korsan-Bengtsen K., Wilhelmsen L., Tibblin G. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. I. Correlations between the variables of clotting and fibrinolysis. Thromb Diath Haemorrh. 1972 Aug 31;28(1):89–98. [PubMed] [Google Scholar]
  10. Millar H. R., Simpson J. G., Stalker A. L. An evaluation of the heat precipitation method for plasma fibrinogen estimation. J Clin Pathol. 1971 Dec;24(9):827–830. doi: 10.1136/jcp.24.9.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Muzaffar T. Z., Stalker A. L., Bryce W. A., Dhall D. P. Structural alterations in fibrin clots with dextran. Thromb Diath Haemorrh. 1972 Oct 31;28(2):257–267. [PubMed] [Google Scholar]
  12. Natelson E. A., Dooley D. F. Rapid determination of fibrinogen by thrombokinetics. Am J Clin Pathol. 1974 Jun;61(6):828–833. doi: 10.1093/ajcp/61.6.828. [DOI] [PubMed] [Google Scholar]
  13. Okuno T., Nelson C. Value of determination of serum fibrin-fibrinogen degradation products in acute myocardial infarction. Am J Clin Pathol. 1974 Feb;61(2):155–159. doi: 10.1093/ajcp/61.2.155. [DOI] [PubMed] [Google Scholar]
  14. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  15. Roberts P. S., Regelson W., Kingsbury B. Determination of fibrinogen in normal human plasma in the presence and absence of anticoagulants. J Lab Clin Med. 1973 Nov;82(5):822–828. [PubMed] [Google Scholar]
  16. Wardle E. N. Fibrinogen in liver disease. Arch Surg. 1974 Dec;109(6):741–746. doi: 10.1001/archsurg.1974.01360060011003. [DOI] [PubMed] [Google Scholar]
  17. Zetterqvist E. Fibrinogen degradation products in experimental intravascular coagulation. Gel filtration and immunological studies. Acta Physiol Scand. 1971 Jul;82(3):289–299. doi: 10.1111/j.1748-1716.1971.tb04970.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES